Focal Low and Global High Permeability Predict the Possibility, Risk, and Location of Hemorrhagic Transformation following Intra-Arterial Thrombolysis Therapy in Acute Stroke

References

1. 1.↵
   2. Hacke W,
   3. Donnan G,
   4. Fieschi C, et al

   ; ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768–74 doi:10.1016/S0140-6736(04)15692-4 pmid:15016487

   CrossRefPubMedWeb of Science
2. 2.↵
   2. O'Rourke K,
   3. Berge E,
   4. Walsh CD, et al

   . Percutaneous vascular interventions for acute ischaemic stroke. Cochrane Database Syst Rev 2010:CD007574 doi:10.1002/14651858.CD007574.pub2 pmid:20927761

   CrossRefPubMed
3. 3.↵
   2. Hong KS,
   3. Kang DW,
   4. Koo JS, et al

   . Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008;15:1324–31 doi:10.1111/j.1468-1331.2008.02310.x pmid:19049549

   CrossRefPubMed
4. 4.↵
   2. Zhang PL,
   3. Wang YX,
   4. Chen Y, et al

   . Analysis on the correlation factors for hemorrhagic transformation after intravenous thrombolytic therapy. Eur Rev Med Pharmacol Sci 2015;19:1001–08 pmid:25855925

   PubMed
5. 5.↵
   2. Moriya Y,
   3. Takahashi W,
   4. Kijima C, et al

   . Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med 2013;38:24–27 pmid:23564572

   PubMed
6. 6.↵
   2. Jiang Q,
   3. Ewing JR,
   4. Chopp M

   . MRI of blood-brain barrier permeability in cerebral ischemia. Transl Stroke Res 2012;3:56–64 doi:10.1007/s12975-011-0133-x pmid:23997835

   CrossRefPubMed
7. 7.↵
   2. Jain AR,
   3. Jain M,
   4. Kanthala AR, et al

   . Association of CT perfusion parameters with hemorrhagic transformation in acute ischemic stroke. AJNR Am J Neuroradiol 2013;34:1895–900 doi:10.3174/ajnr.A3502 pmid:23598828

   Abstract/FREE Full Text
8. 8.↵
   2. Ozkul-Wermester O,
   3. Guegan-Massardier E,
   4. Triquenot A, et al

   . Increased blood-brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke. Eur Neurol 2014;72:45–53 doi:10.1159/000358297 pmid:24853726

   CrossRefPubMed
9. 9.↵
   2. Campbell BC,
   3. Christensen S,
   4. Parsons MW, et al

   ; EPITHET and DEFUSE Investigators. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol 2013;73:510–19 doi:10.1002/ana.23837 pmid:23444008

   CrossRefPubMed
10. 10.↵
    2. Lin K,
    3. Kazmi KS,
    4. Law M, et al

    . Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 2007;28:1292–98 doi:10.3174/ajnr.A0539 pmid:17698530

    Abstract/FREE Full Text
11. 11.↵
    2. Hom J,
    3. Dankbaar JW,
    4. Soares BP, et al

    . Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 2011;32:41–48 doi:10.3174/ajnr.A2244 pmid:20947643

    Abstract/FREE Full Text
12. 12.↵
    2. Patlak CS,
    3. Blasberg RG

    . Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985;5:584–90 doi:10.1038/jcbfm.1985.87 pmid:4055928

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Chen H,
    3. Liu N,
    4. Li Y, et al

    . Mismatch of low perfusion and high permeability predicts hemorrhagic transformation region in acute ischemic stroke patients treated with intra-arterial thrombolysis. Sci Rep 2016;6:27950 doi:10.1038/srep27950 pmid:27302077

    CrossRefPubMed
14. 14.↵
    2. Adams HP Jr.,
    3. Bendixen BH,
    4. Kappelle LJ, et al

    ; TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41 pmid:7678184

    Abstract/FREE Full Text
15. 15.↵
    2. Berger C,
    3. Fiorelli M,
    4. Steiner T, et al

    . Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–35 doi:10.1161/01.STR.32.6.1330 pmid:11387495

    Abstract/FREE Full Text
16. 16.↵
    2. Barber PA,
    3. Demchuk AM,
    4. Zhang J, et al

    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group—Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–74 doi:10.1016/S0140-6736(00)02237-6 pmid:10905241

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Man S,
    3. Hussain MS,
    4. Wisco D, et al

    . The location of pretreatment hyperdense middle cerebral artery sign predicts the outcome of intraarterial thrombectomy for acute stroke. J Neuroimaging 2015;25:263–68 doi:10.1111/jon.12115 pmid:24707921

    CrossRefPubMed
18. 18.↵
    2. Yang Q

    , inventor; Apollo Medical Imaging Technology Pty Ltd, assignee. Method and system for mapping tissue status of acute stroke. US patent 8942451. January 27, 2015
19. 19.↵
    2. Bivard A,
    3. Levi C,
    4. Krishnamurthy V, et al

    . Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain 2015;138(pt 7):1919–31 doi:10.1093/brain/awv071 pmid:25808369

    CrossRefPubMed
20. 20.↵
    2. Sourbron SP,
    3. Buckley DL

    . Classic models for dynamic contrast-enhanced MRI. NMR Biomed 2013;26:1004–27 doi:10.1002/nbm.2940 pmid:23674304

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Patlak CS,
    3. Blasberg RG,
    4. Fenstermacher JD

    . Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1–7 doi:10.1038/jcbfm.1983.1 pmid:6822610

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Arnould MC,
    3. Grandin CB,
    4. Peeters A, et al

    . Comparison of CT and three MR sequences for detecting and categorizing early (48 hours) hemorrhagic transformation in hyperacute ischemic stroke. AJNR Am J Neuroradiol 2004;25:939–44 pmid:15205127

    Abstract/FREE Full Text
23. 23.↵
    2. Hacke W,
    3. Kaste M,
    4. Fieschi C, et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51 doi:10.1016/S0140-6736(98)08020-9 pmid:9788453

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Goldstein LB,
    3. Bushnell CD,
    4. Adams RJ, et al

    ; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517–84 doi:10.1161/STR.0b013e3181fcb238 pmid:21127304

    Abstract/FREE Full Text
25. 25.↵
    2. Wang YJ,
    3. Zhang SM,
    4. Zhang L, et al

    . Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 2012;18:93–101 doi:10.1111/j.1755-5949.2011.00290.x pmid:22313945

    CrossRefPubMed
26. 26.↵
    2. Gobert F,
    3. Cho TH,
    4. Desilles JP, et al

    . Magnetic resonance imaging-based intravenous thrombolysis 6 hours after onset of minor cerebellar stroke. Arch Neurol 2011;68:678 doi:10.1001/archneurol.2011.87 pmid:21555649

    CrossRefPubMed
27. 27.↵
    2. Newman DH,
    3. Shreves AE

    . Thrombolysis in acute ischaemic stroke. Lancet 2012;380:1053–54; author reply 1054–55 doi:10.1016/S0140-6736(12)61593-1 pmid:22998705

    CrossRefPubMed
28. 28.↵
    2. Whiteley WN,
    3. Thompson D,
    4. Murray G, et al

    ; IST-3 Collaborative Group. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke 2014;45:1000–06 doi:10.1161/STROKEAHA.113.004362 pmid:24603072

    Abstract/FREE Full Text
29. 29.↵
    2. Lee M,
    3. Saver JL,
    4. Alger JR, et al

    . Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation. J Neurol Sci 2012;313:142–46 doi:10.1016/j.jns.2011.08.048 pmid:21945462

    CrossRefPubMed
30. 30.↵
    2. Hermitte L,
    3. Cho TH,
    4. Ozenne B, et al

    . Very low cerebral blood volume predicts parenchymal hematoma in acute ischemic stroke. Stroke 2013;44:2318–20 doi:10.1161/STROKEAHA.113.001751 pmid:23723309

    Abstract/FREE Full Text
31. 31.↵
    2. Schneider T,
    3. Hom J,
    4. Bredno J, et al

    . Delay correction for the assessment of blood-brain barrier permeability using first-pass dynamic perfusion CT. AJNR Am J Neuroradiol 2011;32:E134–38 doi:10.3174/ajnr.A2152 pmid:20538824

    Abstract/FREE Full Text
32. 32.↵
    2. Yassi N,
    3. Parsons MW,
    4. Christensen S, et al

    . Prediction of poststroke hemorrhagic transformation using computed tomography perfusion. Stroke 2013;44:3039–43 doi:10.1161/STROKEAHA.113.002396 pmid:24003043

    Abstract/FREE Full Text